London Calling 2025 - Speakers
Speakers
Check out the line up of speakers at London Calling 2025.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
Oxford Nanopore Technologies
Basharat Bhat
)
- Job title
- Institution
- Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST), India
- Biography
Dr Basharat Bhat is a distinguished researcher and educator with over 10 years of experience in the fields of applied bioinformatics and computational biology. Currently serving as an Assistant Professor in the Center for Artificial Intelligence and Machine Learning at SKUAST-Kashmir, Dr Bhat has made significant contributions to the fields of drug development, and marker identification for disease detection and precision medicine. Basharat completed his postdoctoral fellowship at the University of Otago, New Zealand, where his research focused on epigenomics and epitranscriptomics, with particular attention to their implications for human health and development of diagnostic tests for COPD and cardiovascular disease. He is actively involved in several innovative projects that uses omics technologies for advancements in human health and precision medicine. With over 50 high-impact publications in international journals, Dr Bhat is also an author of several books and serves as an editorial board member and reviewer for various reputed journals.
- Recent publications
Fitzgerald, S., Bhat, B., Print, C., Jones, G.T. A validated restriction enzyme ddPCR cg05575921 (AHRR) assay to accurately assess smoking exposure. Clin Epigenetics 16(1):45 (2024).
DOI: 10.1186/s13148-024-01659-1Bhat, B. and Jones, G.T. Gaps in current methods to detect polymorphic CpGs from Illumina Infinium human methylation microarrays and exploring their potential impact in multi-EWAS analyses. Epigenetics 18(1):2281153 (2023). DOI: 10.1080/15592294.2023.2281153
Jones, G.T. et al. DNA methylation profiling identifies a high effect genetic variant for lipoprotein (a) levels. Epigenetics 15(9):949-958 (2020). DOI: 10.1080/15592294.2020.1739797
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.